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Abstract
Background: The boreal forest of Canada is home to several hundred thousands Aboriginal people who have
been using medicinal plants in traditional health care systems for thousands of years. This knowledge, transmitted
by oral tradition from generation to generation, has been eroding in recent decades due to rapid cultural change.
Until now, published reviews about traditional uses of medicinal plants in boreal Canada have focused either on
particular Aboriginal groups or on restricted regions. Here, we present a review of traditional uses of medicinal
plants by the Aboriginal people of the entire Canadian boreal forest in order to provide comprehensive
documentation, identify research gaps, and suggest perspectives for future research.
Methods: A review of the literature published in scientific journals, books, theses and reports.
Results: A total of 546 medicinal plant taxa used by the Aboriginal people of the Canadian boreal forest were
reported in the reviewed literature. These plants were used to treat 28 disease and disorder categories, with the
highest number of species being used for gastro-intestinal disorders, followed by musculoskeletal disorders. Herbs
were the primary source of medicinal plants, followed by shrubs. The medicinal knowledge of Aboriginal peoples
of the western Canadian boreal forest has been given considerably less attention by researchers. Canada is lacking
comprehensive policy on harvesting, conservation and use of medicinal plants. This could be explained by the
illusion of an infinite boreal forest, or by the fact that many boreal medicinal plant species are widely distributed.
Conclusion: To our knowledge, this review is the most comprehensive to date to reveal the rich traditional
medicinal knowledge of Aboriginal peoples of the Canadian boreal forest. Future ethnobotanical research
endeavours should focus on documenting the knowledge held by Aboriginal groups that have so far received less
attention, particularly those of the western boreal forest. In addition, several critical issues need to be addressed
regarding the legal, ethical and cultural aspects of the conservation of medicinal plant species and the protection
of the associated traditional knowledge.
Keywords: Medicinal plants, traditional knowledge, boreal forest, Aboriginal people, Algonquian, Athapaskan, con-
servation, management, policy
Background
Medicinal plants have been used in traditional health
care systems since prehistoric times and are still the
most important health care source for the vast majority
of the population around the world [e.g. [1-6]]. It is esti-
mated that 70-80% of people worldwide rely on tradi-
tional herbal medicine to meet their primary health care
needs [7,8]. Globally, millions of people rely on
medicinal plants not only for primary health care, but
also for income generation and livelihood improvement
[8]. Annual sales of herbal-based medicines range
between 7.5 billion US$ and 108 billion US$ worldwide,
the latter number representing sales of processed medi-
cines [9]. In Canada annual market sales of medicinal
plants reached 400 million US$ in 2001 [10], and are
growing at a pace of 15% annually [11].
Through millennia of trial and error, indigenous peo-
ple have gained substantial knowledge of medicinal
plants which has been transmitted from generation to
generation as part of oral traditions [12,13]. However,
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concerns are being raised about the loss of native
knowledge and the possible extinction of medicinal
plant resources due to disruptions to traditional ways of
life induced by colonial forces [14-17]. Hence, proper
documentation of traditional knowledge regarding plant
use, along with conservation and sustainable manage-
ment of key habitats, could contribute to safeguarding
this heritage [18].
A few studies have attempted to review the use of
medicinal plants by the Aboriginal people of Canada,
but they focused either on particular Aboriginal groups
[e.g. [19]], or on restricted regions [e.g. eastern Canada
[20]]. Here we present a review of the traditional use of
medicinal plants by the Aboriginal peoples of the Cana-
dian boreal forest. Furthermore, we provide complemen-
tary information on conservation status of medicinal
plant species, as well as on policies framing medicinal
plant use and traditional knowledge. Finally, we identify
gaps in knowledge, and suggest perspectives for future
research.
Canada’s Aboriginal People and the Boreal Forest
Sometimes called the land of much geography and little
history [21], Canada is blessed with an immense forest
endowment [22]. The circumboreal forest is the most
extensive terrestrial biome in the world, encompassing
some 14 million km2 and 32% of the Earth’s forest
cover. Thirty percent of this world resource is found in
Canada, where it occupies 58% of the nation’s land area
comprising seven boreal and taiga ecozones [23]. Cana-
da’s boreal ecozones cover 5.8 million km2, of which 4.3
million km2 are forested [24]. The boreal forest of
Canada is a broad vegetation zone (Figure 1) that
stretches from the northern Atlantic coast westward to
the Rocky Mountains, across the southwestern North-
west Territories and Yukon. The southern edge borders
the eastern hardwood forest, abuts the north shores of
the Great Lakes, and in the west intergrades with the
aspen parkland and prairie. The northern edge fades
into the tundra.
According to the 2006 census [25], there were 1 172
790 Aboriginal people in Canada (including First
Nations, Metis and Inuit), representing ca. 4% of the
total population. The proportion of Aboriginal people is
much higher in the boreal zone [26], reaching more
than 30% of the total population in several areas [27].
Aboriginal peoples of the Canadian boreal forest are
part of two major linguistic groups [28]: the central and
eastern boreal forest is home to peoples of the Algon-
quian linguistic group (Mi’kmaq, Malecite, Abenaki,
Penobscot, Innu/Montagnais, Cree, Atikamekw, Algon-
quin/Anishinabe, Ojibwa/Anishinabe, Chippewa),
whereas the northwestern boreal forest is home to
peoples of the Athapaskan linguistic group (Chipewyan,
Dene, Gwich’in, Sekani)i (Figure 1).
Canada’s forests have long played an integral role in
supporting the lives of Aboriginal people, meeting their
physical, cultural, spiritual and material needs. Tradi-
tional knowledge related to medicinal plants has been
instrumental in the survival and wellbeing of Aboriginal
people for thousands of years [29]. Unfortunately, this
type of knowledge has been seriously eroding over the
past decades [14,29] indicating challenges for restora-
tion. The concept of Aboriginal forestry, increasingly
used in recent years [30-33], provides a means to keep
indigenous cultures healthy and connected to the land
[34-36]. Aboriginal communities possess their own tra-
ditional knowledge that contributes to a broader under-
standing of native plant species, many of which have yet
to be studied by “western” scientists.
Methods
We reviewed scientific studies published in journals,
books, theses and reports. Pertinent literature was
searched in different electronic databases (ISI Web of
Science, MEDLINE, Science Direct, Scopus, and Goo-
gle Scholar) using specific search terms such as “med-
icinal plants”, “traditional”, “Aboriginal OR First
Nation OR Indigenous OR Indian”, “boreal”, and
“Canada”. We do not claim to have included every
existing information source about traditional uses of
medicinal plants, but we rather chose to focus on
information easily accessible to researchers (available
on the internet or through interlibrary loan). We are
aware that several Aboriginal communities have endea-
voured to record their members’ traditional knowledge
related to medicinal plants over the last few decades.
However, in most cases, this information has yet to be
made available to outsiders.
We reviewed a total of 49 publications that provided
information about the use of medicinal plant species to
treat various ailments. We only used publications pre-
senting first-hand ethnobotanical information. Previously
published reviews were consulted but were not included
in the analyses. A master list was produced, showing
name(s), part(s) used, use(s), and reference(s) for each
species (Additional file 1).
Although we focused our search on traditional medic-
inal practices of Aboriginal people living in the Cana-
dian boreal forest, some of the inventoried plants are
distributed partly or entirely outside the boreal forest (e.
g., in the temperate forest or in arctic or alpine areas).
Large-scale trade networks between different nations are
known to have existed in the past [37], allowing boreal
peoples to obtain plants from contiguous areas in
exchange for other goods.
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The precision of botanical identification in this review
depended on that from original sources. Latin names
and native status (native vs. introduced) were verified in
the Plant Database of the United States Department of
Agriculture, Natural Resources Conservation Service
[38], the Plant Database of the Missouri Botanical Gar-
den [39], the Flora of North America [40], and the
Canadian Vascular Plants Database (VASCAN) [41].
Whenever available, subspecies (ssp.) and variety (var.)
names are also provided. The currently accepted name
is followed by synonyms, when provided in the source
references. In some cases, only the genus was provided
in the literature [e.g. [42-44]] and we did not attempt to
refine the information to the species level.
The Aboriginal plant names mentioned in this review
were taken textually from the original sources, whenever
they were reported. Since North American Aboriginal
cultures were based on oral tradition prior to European
contact, various spellings exist for the same word. No
selection was done and all variants are provided. Most
Aboriginal languages are descriptive and thus the name
given to a plant often refers to its appearance or func-
tion rather than to genetic uniqueness. Identical names
are thus sometimes given to different species, or differ-
ent names to the same species. To some extent, the
approach shows similarities with the concept of plant
functional traits [45].
Traditional plant uses are provided with the name of
the Aboriginal group whenever the information was
available, and the reference from which the information
was retrieved. We followed the method proposed by
Cook [46] to classify plants according to the different
ailment categories they help to cure. However, in some
cases Cook’s [46] categories were not precise enough
and plants were assigned to additional ailment
categories.
Figure 1 The boreal forest of Canada, and names and approximate locations of Aboriginal peoples discussed in this review. Note that
although Metis communities are found in most of Canada, it is the communities from the central provinces that were reported in the studies
included in this review.
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Ethnomedicine of Boreal Canada
Traditional medicine among the Aboriginal peoples of
the Canadian boreal forest is based on oral tradition
transmitted through several generations [13,47]. It is a
cultural phenomenon, dynamic and adaptive, like lan-
guage and other cultural manifestations [13]. The holis-
tic approach of Aboriginal healing systems involves
spirituality and intimate connection with the natural
environment [47,48]. It also involves strong community
networks of people who participate in the process of
healing, and who can direct community members to
people who have the knowledge to facilitate healing.
Vogel [49] compiled the historical context of Aborigi-
nal peoples’ medicinal culture and discussed shamanistic
and spiritual aspects. Moerman [50-52] published some
of the most complete ethnobotanical compilations for
North America, including boreal Canada. Shemluck [53]
provided a review of the medicinal uses of species from
the Asteraceae family by North American Aboriginal
people. Andre et al. [54] compiled the medicinal knowl-
edge of Arctic and Subarctic indigenous people.
Ethnomedicine of Eastern and Central Canada
Assiniwi [55] and Erichsen-Brown [56] reported uses of
medicinal plants by eastern North American Aboriginal
people. Foster and Duke [57] published a useful field
guide to the medicinal plants of central and eastern
North America. Arnason et al. [20] reported on some
400 medicinal plants used in traditional health care sys-
tems by Aboriginal people of eastern Canada. Only for
the Maritimes, 128 medicinal plant species were
reported to be used by Chandler et al. [58]. Medicinal
plants knowledge of Aboriginal people from the Mari-
times has also been explored by several other research-
ers [43,48,59-65]. Youngken [44,66] studied the
medicinal knowledge of several groups from the north-
eastern United States and Canada and Rousseau [67]
worked with the Abenaki. Speck [63] reported on
Algonquian peoples’ knowledge, whereas Marie-Victorin
[68] and Black [69] specifically worked with the Algon-
quin. Tantaquidgeon [70], Clément [71] and Laurendeau
[72] explored Montagnais (Innu) knowledge, Raymond
[73] worked with the Atikamekw, whereas Holmes [42],
Strath [74], Jenkins [75], Beardsley [76], Grandi [77],
Williams and Glover [78], Iserhoff et al. [79], Marshall
[80,81], Fraser [82] and Leduc et al. [83] focused on
Cree territory. The Ojibwa knowledge of medicinal
plants has long been a subject of great attention and it
has therefore contributed a lot to the ethnobotany lit-
erature of the Central boreal region [47,84-89]. Some of
these studies were reviewed and compiled by Meeker et
al. [19] who provided detailed information about 384
plants used by the Ojibwaii. Davidson-Hunt et al. [90]
provided identification, classification and nomenclature
systems for plants used by the Ojibwa. Beresford-Kroe-
ger [91] provided some information about traditional
medicinal uses of tree species found in northeastern
North America.
Ethnomedicine of Western Canada
Marles et al. [13] described the traditional use of plants
by Cree, Dene, and Métis peoples of Manitoba, Sas-
katchewan, and Alberta. This study also partly covered
eastern Canada, and it is the only one to cover Métis
medicinal culture. Marles [92] also worked with the Chi-
pewyan of northern Saskatchewan. Siegfried [93] docu-
mented the ethnomedicinal knowledge of the Alberta
Cree. Leighton [94,95] and Clavelle [96] studied the
Crees of Saskatchewan and Smith [97] reported on med-
icinal plant uses by the Sekani of British Columbia. Stu-
dies were also conducted with First Nations from the
Dene group in the western boreal region: the Fisherman
Lake Slave [98] the Prophet River First Nation [17], the
Gwich’in [99,100] and the Dogrib [101].
Taxonomic Diversity, Growth habit and Parts Used
We report on a total of 546 medicinal plant taxa used
by Aboriginal peoples of the Canadian boreal forest
(Additional file 1). Although most information was
available at the species or even subspecies level, some-
times only the genera was provided. Among the most
commonly used plants were: Abies balsamea (L.) Mill.,
Achillea millefolium L., Acorus calamus L., Aralia nudi-
caulis L., Betula papyrifera Marsh., Cornus sericea L.,
Heracleum maximum Bartram, Juniperus communis L.,
Larix laricina (Du Roi) K. Koch, Menta arvensis L.,
Nuphar lutea (L.) Sm, Picea glauca (Moench) Voss,
Picea mariana (Mill.) BSP, Populus balsamifera L.,
Populus tremuloides Michx, Rhododendron groenlandi-
cum (Oeder) K.A. Kron & W.S. Judd., Salix sp., Sorbus
americana Marsh, and Thuja occidentalis L. Angios-
perms were predominant, with 474 taxa belonging to 90
families, followed by Pteridophytes (21 taxa from 5
families), Gymnosperms (21 taxa from 3 families), Fungi
(13 taxa from 7 families), Lichens (11 taxa from 4
families), and Bryophytes (6 taxa from 2 families) (Fig-
ure 2). Well represented Angiosperm families were
Asteraceae (62 species), Rosaceae (48), Liliaceae (21),
Ericaceae (18), Betulaceae (18), Caprifoliaceae (18),
Ranunculaceae (16), Salicaceae (16), Polygonaceae (15)
and Lamiaceae (13). The prevailing growth habit (sensu
[38]) of angiosperms medicinal plant taxa was herb (307
species), most likely because they are more abundant
(Figure 3). The more abundant a plant is, the more
likely it is to be used. The next dominant growth habit
of angiosperm taxa was shrub (86), followed by tree (69)
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and vine (12). Of the 21 gymnosperm taxa, 19 were
trees and 2 were shrubs. All dominant species of angios-
perms and gymnosperms of the boreal forest were being
used as medicinal plants. Furthermore, forty-nine intro-
duced species were part of the native pharmacopoeia
(Additional file 1).
Almost all plant parts were used to prepare different
remedies: roots, rhizomes, stem, bark, leaves, flowers,
fruits, young shoots, and whole plants (Additional file
1). The most frequently used plant parts were roots, fol-
lowed by leaves, whole plants, fruits, and rhizomes.
Ailments Treated and Preparation Methods
A total of 28 major ailment categories were treated with
medicinal plants (Table 1). Gastro-intestinal disorders,
musculoskeletal disorders, cold, cough and sore throat,
injuries, respiratory system disorders, urinary system dis-
orders, and dermatological infections were treated with
the highest diversity of medicinal plant species (Table 1,
Additional file 2).
Preparation methods included paste, poultice, juice,
decoction, infusion, and chewing the raw plant (Table 2,
Additional file 1). The majority of formulations were
prepared as decoction or infusion (Additional file 1).
Some formulations were prepared using combinations of
different plants, sometimes as many as 20 substances
being combined in one remedy [47]. Some formulations
also included animal organs or fat [47,85,95]. Proper
selection of species, parts, as well as preparation and
administration methods are all very important in tradi-
tional health care systems [17,81]. Medicinal plant use
should be carried out under the supervision of a knowl-
edgeable person [81], usually an elder [102], as some
plants might be poisonous (even lethal, e.g., Cicuta,
Figure 2 Frequency of medicinal plant taxa in major
taxonomic categories.
Figure 3 Frequency of medicinal flowering plant taxa in
different growth habits.
Table 1 Major ailment categories and taxa reported.
Ailment category Number of
taxa*
Number of use
reports
Blood system 39 17
Circulatory system 53 16
Cold, cough and sore
throat
130 19
Dermatological 100 40
Diabetes 42 7
Ear 20 17
Fainting and fits 18 9
Fever 62 22
Gastro-intestinal system 214 26
General 89 26
Gynaecological 85 20
Haemorrhages 38 19
Hair 14 7
Headache 69 28
Injuries 119 36
Mental 18 9
Metabolic system 20 11
Musculoskeletal system 134 34
Nervous system 31 12
Nutritional 70 24
Odontological 44 23
Ophthalmological 57 27
Poisoning 41 16
Pregnancy/Birth/
Puerperium
83 22
Respiratory system 118 32
Sexual dysfunction 3 2
Urinary system 109 33
Venereal 28 14
*Most taxa were reported in more than one ailment category (see Additional
file 1).
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Taxus, Veratrum), or could cause adverse reactions
when taken in combination with other plants or with
western medicine.
In some Aboriginal medicinal cultures the various
processes of healing are connected with ceremonies and
rites [47,70]. Those who possess the secret cures some-
times think that if they disclose them too freely the
herbs will lose their potency [63]. When a plant is col-
lected, it is important to leave a small offering (tobacco,
matches, tea, rifle or shotgun shells, money, sugar or a
prayer) in place of what is taken [17,20,99]. This ritual
shows respect for the plant and increases the healing
power of the medicine [20]. The season of collection
and proper storage conditions are considered important
for the effectiveness of remedies. Plants are usually gath-
ered in late summer or early fall, when fully developed
[47,58]. In some instances the fertile and sterile plants
are considered separately [47]. When bark is used, it is
sometimes collected from the eastern side of the tree
[65,70]. When roots are used, the healing power is
deemed stronger in certain portions than in others [47].
Medicinal plants harvesting practices are integral to the
healing process, and crucial for resource preservation.
Phytochemical and Pharmacological Studies of Boreal
Canadian Medicinal Plants
The most frequent approach to species selection for
phytochemical, pharmacological or antimicrobial analy-
sis is by reviewing the ethnobotanical literature. This
highlights the importance of such studies in western
pharmacognosy. Phytochemical and pharmacological
studies investigating medicinal properties of North
American plant species used to be lacking [20]. How-
ever, there was a marked increase in such studies in
recent years, pinpointing the active principles of many
plants used by Aboriginal peoples of Canada [12]. Exam-
ples of such studies are: Chandler and Hooper [103],
Wat et al. [104], Chandler and Hooper [105], Hooper
and Chandler [106,107], Bergeron et al. [108], Owen
and Johns [109], Jones et al. [110], Lin et al. [111],
McCune and Johns [112-114], Ficker et al. [115], Bafi-
Yeboa et al. [116], Spoor et al. [117], Awad et al. [118],
Tsao and Liu [119], Webster et al. [120], Marles [92]
and Martineau et al. [121].
At the species level, Chandler et al. [122,123] high-
lighted the correspondence between traditional use and
phytochemical and pharmacological properties of Achil-
lea millefolium and Tanacetum vulgare, two of the most
widely used medicinal plant species in boreal Canada
(Additional file 1). Applequist and Moerman [124] also
reviewed ethnobotany and bioactivity of Achillea mille-
folium. Dufour [125] and de Moor [126] respectively
studied biological activity in Rhododendron groenlandi-
cum and Abies balsamea. Saxena et al. [127] analyzed
the antimicrobial activities of Rhus glabra, Kobaisy et al.
[128] highlighted the antimycobacterial activity of Oplo-
panax horridus, Kitts et al. [129] and Vuksan and Sie-
venpiper [130] considered Panax quinquefolius, Murch
et al. [131]Hypericum perforatum, Petzke et al. [132]
Taxus canadensis, and Matsuo et al. [133] Caulophyl-
lum thalictroides. Matsuura et al. [134] worked on
Empetrum nigrum.
Several studies were conducted on the anti-diabetic
properties of medicinal plants, as diabetes is a serious
concern for Aboriginal people of Canada
[83,117,135-138]. Most of the scientific research into the
anti-diabetic properties of boreal medicinal plants has
been done in partnership with Cree communities of
northern Quebec.
Conservation and Management of Medicinal
Plants
Conservation and management of traditional medicinal
plants is an important issue worldwide, mostly in devel-
oping countries where medicinal plants are primary for-
est products for rural communities. The nature of the
interactions between traditional practices and local eco-
systems can be both positive and negative depending on
Table 2 Common forms of preparation methods for remedies made of medicinal plants.
Preparation
method
Description
Paste Fresh plant parts are crushed to obtain a paste used externally or internally.
Poultice Plant parts are crushed to obtain a soft moist mass generally used externally to treat swellings, pain, inflamed or infected body
parts.
Juice Obtained by squeezing or crushing plant parts and filtering through cloth. Sometimes requires addition of freshwater or other
liquid for dilution.
Powder Obtained by crushing dried plant parts.
Chewing Fresh plant parts are chewed without prior transformation.
Infusion Plant parts are plunged in either hot or cold water for several minutes. If hot water is used infusion is taken as a tea. More than
one plant species can be used in conjunction.
Decoction Plant parts are boiled in water for several minutes and the extract is used. More than one plant species can be used in
conjunction.
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use intensity, intent (for local/personal use or for com-
mercial use) and magnitude of exploitation [139]. Plants
should only be collected in such a manner that ensures
their continued presence, both in specific collection
locations and across the landscape [19]. One of the big-
gest threats to the survival of medicinal plant species is
habitat loss due to infrastructure development, mining,
forestry, oil and gas exploitation, and hydro power gen-
eration projects [19]. Because many plant species have
medicinal properties, their conservation could foster the
preservation of important habitats for other species of
plants and wildlife.
Conservation and management of medicinal plants has
been given less attention in Canada than elsewhere,
although it has been discussed recently [19,140-143].
Some management issues have been raised related to
non-timber forest products (NTFPs), but without special
focus on medicinal plants [144,145]. The most serious
threats to boreal plants are habitat loss and fragmenta-
tion, climate change, and invasive species [143]. It is not
known whether overexploitation is an issue in boreal
Canada, as it is in several countries worldwide [18].
According to Westfall and Glickman [140], there is no
formal system of accounting for medicinal plant harvest-
ing in Canada, and thus little is known about which
plants are being harvested, from where, and in what
quantity. It could be too late to address conservation
issues as the lack of a proper accounting system does
not offer an up-to-date portrait of the status and scale
of exploitation of medicinal plants. High pressure from
the timber harvesting industry poses severe threats to
medicinal plants in boreal Canada, especially to species
associated to old-growth forests.
An integrated, collaborative approach for sustainable
use, conservation and management of medicinal plants
should be put into place and involve all stakeholders
[146]. However, local peculiarities should be taken into
account and the role of stakeholders might be different
in different locations as the Aboriginal peoples of boreal
Canada have different legal relationships with the federal
and provincial governments. National level conservation
policies do not necessarily apply within reserve bound-
aries. Furthermore, treaties and agreements between the
governments and some First Nations have granted the
latter different levels of control over natural resources
[147].
Special care has to be given when attributing a legal
protection status to a species because of over-harvesting
by non Aboriginal people, as it will prevent Aboriginal
people from using a resource they have been counting
on for centuries. Furthermore, small-scale, aboriginal-led
businesses based on in situ collection of medicinal
plants provide interesting sustainable livelihood options.
Special efforts have thus to be made to identify
important plant collection areas [148]. Zoning tools
could be especially helpful to decision making [149].
Of the 546 plant species included in this review, only
six were listed as imperilled according to the Species at
risk public registry [150]: Betula lenta, Cornus florida,
Panax quinquefolius, Juglans cinerea, Solidago speciosa
were endangered, whereas Aletris farinosa was threa-
tened. Such a low percentage of species at risk could
probably be explained by three factors: (1) most boreal
plants have extensive distributions, (2) the boreal zone
has been less impacted by human activities than more
southern areas, and (3) the plants used by aboriginal
people tend to be the more common ones.
Challenges to Traditional Medicinal Plants
Research
Aboriginal people of Canada are worried that their
knowledge could be stolen by profit-seeking pharmaceu-
tical companies without acknowledging or involving
communities [143], and without proper compensation
being given in return. Concerns about the respect of
intellectual property rights thus render most Aboriginal
people reluctant to disclose their knowledge to outsiders
[151], especially as legal protection is insufficient. This
could explain why published ethnobotanical studies
were somewhat less numerous in boreal Canada
between the 1950s and 1970s (Figure 4). Informal dis-
cussions with Cree and Algonquin communities from
Northern Quebec indeed revealed that Aboriginal peo-
ple are cautious in reaction to misguided research prac-
tices by academics and government agencies. The
historical background where Aboriginal people have suf-
fered more inconveniences than they have benefited
from European settlement is doubtless contributing to
Figure 4 Number of studies included in this review for each
decade between 1881 and 2010.
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this generalized mistrust [21]. Also important is that
land claims have not yet been settled for most Aborigi-
nal communities and nations [152,153]. Aboriginal peo-
ple would probably be more open to share their
knowledge if they had more power in land governance
[154].
In such conditions ethnobotanists face important chal-
lenges related to trust building and safeguarding tradi-
tional people’s intellectual property rights. Nevertheless,
a trustful environment can be favoured by considering
the following ethical principles [after CNR [142]]:
- respect Aboriginal culture and protect sensitive
and confidential information;
- ensure that knowledge ownership and project lea-
dership resides with Aboriginal people;
- share benefits with communities;
- contribute to capacity building in Aboriginal
communities;
- take into account and protect the interrelationship
between environment, health and culture;
- obtain clear and informed consent from research
participants, pay careful attention to ethical and
legal issues, and obtain ethical approval of research
protocols;
- respect Aboriginal and treaty rights.
Policy and Institutional Framework Related to
Medicinal Plants
International Perspective
Since its adoption in 1992, the United Nations Conven-
tion on Biological Diversity (CBD) has strived to imple-
ment its three major goals: conservation of biological
diversity, sustainable use of its components, and a fair
and equitable sharing of the benefits from the use of
genetic resources [155]. Although medicinal plants were
not explicitly on the agenda of the various CBD meet-
ings, all three goals of the Convention are fully applic-
able to medicinal plant resources [156]. According to
CBD’s Article 8 (j): Traditional Knowledge, Innovations
and Practices, signatories agree to
“respect, preserve and maintain knowledge, innova-
tions and practices of indigenous and local commu-
nities embodying traditional lifestyles relevant for the
conservation and sustainable use of biological diver-
sity and promote their wider application with the
approval and involvement of the holders of such
knowledge, innovations and practices and encourage
the equitable sharing of the benefits arising from the
utilization of such knowledge innovations and
practices”.
Agenda 21 and Forest Principles adopted at the UN
Conference on Environment and Development
(UNCED) identified forest products other than wood
(also called non-timber forest products or NTFPs) as an
important area requiring increased attention and as a
source of environmentally-sound and sustainable devel-
opment [157]. Since the Johannesburg Earth Summit in
2002, much attention has been given to the possibility
of combining biodiversity conservation and poverty alle-
viation [158]. Via their legislations, countries are obliged
to implement these various policy measures to ensure
that traditional knowledge and intellectual property
rights are respected [159]. The Conference of the Parties
to the Convention on Biological Diversity held in
Nagoya (Japan) in 2010 discussed the access and benefit
sharing issues of sustainable use of biodiversity [160].
The Agreement on Trade Related Aspects of Intellectual
Property Rights mandates countries to safeguard intel-
lectual property rights [159]. The UN Declaration on
the Rights of Indigenous Peoples, Article 24 includes
provisions for use of resources (including medicinal
plants) and rights over territories [161]:
“Indigenous peoples have the right to their traditional
medicines and to maintain their health practices,
including the conservation of their vital medicinal
plants, animals and minerals. Indigenous individuals
also have the right to access, without any discrimina-
tion, to all social and health services”.
The World Health Organization (WHO) has drafted
several guidelines and passed resolutions for the integra-
tion of traditional health care systems and remedies into
national health policies and regulations [8,162-165]. The
specific guidelines on conservation of medicinal plants
are provided in WHO et al. [165]. Organizations like
WHO, the World Wildlife Fund (WWF), the World
Conservation Union (IUCN), the UN Food and Agricul-
ture Organization (FAO), the wildlife trade monitoring
network-TRAFFIC, the International Development
Research Centre (IDRC), and Plant Life International
have been involved in the medicinal plants sector for a
long time [see [8,165,166]].
Various recommendations have been made on the use
and conservation of medicinal plants, such as those
associated with international conferences at Chiang Mai,
Thailand, in 1988, and Bangalore, India, in 1998 and
2009 [18,167]. They included the need for co-ordinated
conservation action, based on both in situ and ex situ
strategies; inclusion of community and gender perspec-
tives in the development of policies and programmes;
the need for more information on medicinal plants
trade; establishment of systems for inventorying and
monitoring medicinal plants status; development of sus-
tainable harvesting practices; encouragement of micro-
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enterprise development by indigenous and rural com-
munities; and protection of traditional resources and
intellectual property rights [18]. The recent International
Healers’ Conference on Promotion of Traditional Medi-
cine for Sustainable Healthcare [167] called for the pro-
motion of self-regulation of all traditional health
professions, capacity building in local communities to
develop biocultural protocols, integration of traditional
medicine into national healthcare systems, and establish-
ment of a Permanent Forum on Traditional Health
Practices at the United Nations.
The regulation of existing markets by setting environ-
mental standards for international trade is a traditional
instrument advocated by international environmental
policy [168]. Biodiversity conservation oriented trade
policy measures are components of international agree-
ments (e.g., the listing of species in CITES appendices
and banning of certain species for trade on the interna-
tional market). Likewise, the General Agreement on
Tariffs and Trade (GATT) also regulates biodiversity
trade and imposes certain restrictions on international
trade of plant resources, including several species of
medicinal plants. Existing guidelines for the sustainable
collection of NTFPs provide useful models for medicinal
plants, including the Forest Stewardship Council (FSC)
sustainable forest management standard, the Interna-
tional Federation of Organic Agricultural Movements
(IFOAM), and Fairtrade Labelling Organizations Inter-
national (FLO) [2].
National Perspective
Comprehensive national policy, laws and regulations
on traditional medicine do not exist in Canada [10].
Nevertheless, Aboriginal and treaty rights are protected
by the constitution of Canada, and this is reflected in
forest policy and forest management practices. Cana-
da’s National Forest Sector Strategy (1988, reviewed
and revised in 1992, 1998, 2003 and 2008) included
provisions for ensuring rights and participation of
Aboriginal people and incorporating traditional knowl-
edge, cultural values and practices in managing forest
lands [22,169,170]. Involvement of Aboriginal people
in developing non-timber forest products and the role
they play in sustainable forest management have been
recognized [22]. The economic development of NTFPs
for diversification of the forest industry is one of the
important aspects of sustainable management of Cana-
da’s forest [13]. Canada is also an active participant of
multilateral and bilateral international treaties and
conventions including Forest Principles and CBD
adopted in 1992 in Rio, and CITES [22]; ensuring con-
servation and sustainable management of medicinal
plants, as well as protection of indigenous knowledge.
Canada has recently - although belatedly - ratified the
UN Declaration on the Rights of Indigenous Peoples
that reaffirms the country’s commitment to promoting
and protecting the rights of Indigenous peoples and
their resources [171].
Sustainable Forests: A Canadian Commitment pub-
lished in 1992 [172] was signed by governments, indus-
try, non-governmental organizations, Aboriginal people,
and communities. It responded to international initia-
tives and commitments, including the UNCED and
Agenda 21. The Canadian government has implemented
the Species at Risk Act in 2002 to protect endangered
and threatened species [173]. Equivalent legislations also
exist at the provincial level [140].
The Natural Health Products Directorate of Health
Canada is a governing body for the regulation of plant
remedies. The Canadian policy on “Natural Health Pro-
ducts Regulations” includes herbal medicines among
other things and was implemented in 2004 by the Nat-
ural Health Products Directorate [174,175]. The pro-
gram has identified indigenous medicinal plants and
Aboriginal contributions and approaches to alternative
health care as priority research areas [141].
Forest Certification and Aboriginal Medicinal Plants of
Canada
Forest certification provides important benefits to forest
communities and certified forests are increasing in pro-
portion since the beginning of the 1990’s. Canada is
leading the world in terms of total area of certified for-
est and proportion of managed forests that have been
certified [176]. Certification standards mandate forest
companies to protect biodiversity and Aboriginal cul-
ture. Specific criteria protect the rights of Aboriginal
people, ensure preservation of Aboriginal resources, tra-
ditional knowledge and land, and compensation of Indi-
genous people for the use of their traditional knowledge
in forest management [176]. These provisions provided
by forest certification standards could benefit Aboriginal
people by providing opportunities for protecting not
only timber, but also non-timber forest values, including
medicinal plants [177]. Interestingly, certification has
proven equally, or even more effective than legislation
to ensure protection of species, habitats and culture, as
pressure from the market is often stronger than from
governments.
Trends, Gaps and Future Directions
Ethnobotanical research in the Canadian boreal forest
has so far focused on plant use by Aboriginal people
from the eastern boreal zone. The Mi’kmaq and Male-
cite nations of the Maritimes are among the most stu-
died groups [e.g. [43,48,60-65]], along with the Ojibwa/
Chippewa [e.g. [47,84-89]. In Quebec, Cree and Innu
cultures have been given more attention [e.g.
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[42,70-83]]. The northwestern zone of the boreal forest
has received less attention [but see [13,17,54,92-99].
After the 1960s, there has been a shift from ethnobo-
tanical studies to phytochemical, antimicrobial and
pharmacological studies. Notwithstanding the impor-
tance of phytochemical, antimicrobial and pharmacolo-
gical studies, ethnobotanical efforts should continue,
especially in areas and within nations that have received
less attention so far, or for which publicly available
material is scarce. For example, studies should be con-
ducted in the northwestern Canadian boreal forest,
notably with the Metis and with peoples of the Athapas-
kan language family, as well as with the Naskapi from
northeastern Quebec. To diversify the scope of ethnobo-
tanical studies, new methods should be adopted, for
field work as well as for data analysis [e.g. [83,178-182]].
Studies are needed to determine if, for the same active
principle and at the same dosage, the efficiency is differ-
ent for traditional and western remedies. Possible inter-
actions between medicinal plants and western medicine
or between different species of medicinal plants also
need to be investigated [183-185]. Studies are also
needed in pharmacognosy, i.e. the standardization,
authentication and study of natural drugs [186]. The uti-
lization of animal products (alone or in combination
with plants) to treat ailments has been given far less
attention than medicinal plants, despite major potential
[187].
From a governance point of view, gender-based or
intergenerational knowledge differences related to med-
icinal plant use should be better documented. Studies
are also needed to determine how traditional medicine
could be given a larger place in modern health care sys-
tems [188-192].
Policy issues about traditional medicinal practices have
not yet been properly addressed in Canada [10]. The
recent adoption of the UN Declaration on the Rights of
Indigenous People could provide incentives in this
regard. Canada is also lagging behind in terms of regula-
tions about conservation and management of medicinal
plants. As suggested by Westfall and Glickman [140],
Canada requires an enforceable policy that protects wild
medicinal plants, effective monitoring system for com-
mercial harvesting, and policy incentives for the cultiva-
tion of medicinal plants in order to reduce harvesting
pressure of wild plants. However, harvesting medicinal
plants from cultivated fields instead of natural forests
might affect spiritual and ceremonial aspects, possibly
with reduced medicinal effects [156].
Conclusion
Medicinal plants represent a significant contribution to
human health and one of the most significant ways in
which humans directly reap the benefits provided by
biodiversity [7,17]. Use of medicinal plants by Aboriginal
people from the Canadian boreal forest has a long his-
tory [11]. Here we reported on 546 medicinal plant spe-
cies used in the traditional health care systems of
Aboriginal people from the Canadian boreal forest. This
is the most comprehensive review to date and it shows
striking similarities between medicinal plant uses in dif-
ferent nations. Thus, by triangulation, it is probably still
possible to document most of the knowledge, but
research should continue, especially in areas or within
nations that have received less attention.
Endnotes
i Only the names of the peoples mentioned in this
review are provided. The Algonquian and Athapaskan
language families include other peoples not listed here.
The names are those that are currently in use and dif-
ferent names were sometimes provided in the older
literature.
ii Anishinabe is the correct name for this people and it
is how they refer to themselves. Ojibwa and Chippewa
are names given to them by other tribes or by non-
aboriginal people [see [19]]. The Algonquin also call
themselves Anishinabe (or Anicinape) [33].
Additional material
Additional file 1: Medicinal plants used by the Aboriginal people of
boreal Canada. Plants are sorted by scientific name. For each plant,
family name, growth habit, vernacular name(s), part(s) used, use(s), and
reference(s) are provided.
Additional file 2: Major disease categories and associated medicinal
plants used by the Aboriginal people of boreal Canada.
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